|
|||||
|
|
Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies |
|
| Authors: | Betty B Yao Linda M Fredrick Gretja Schnell Kris V Kowdley Paul Y Kwo Fred Poordad Kinh Nguyen Samuel S Lee Christophe George Florence Wong Edward Gane Armand Abergel Catherine W Spearman Tuan Nguyen Manh Hung Le Thuy TT Pham Federico Mensa Tarik Asselah |
| Abstract: | |
| Keywords: | genotype 5 genotype 6 glecaprevir and pibrentasvir hepatitis C integrated analysis phase 2 and 3 |